Published in Ann Intern Med on July 15, 2008
Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. BMJ (2015) 2.18
Mechanical compression versus subcutaneous heparin therapy in postoperative and posttrauma patients: a systematic review and meta-analysis. World J Surg (2010) 1.68
Arthroscopic surgery for degenerative knee: systematic review and meta-analysis of benefits and harms. Br J Sports Med (2015) 1.04
Thromboprophylaxis in routine arthroscopy of knee. Indian J Orthop (2013) 0.82
II Italian intersociety consensus statement on antithrombotic prophylaxis in orthopaedics and traumatology: arthroscopy, traumatology, leg immobilization, minor orthopaedic procedures and spine surgery. J Orthop Traumatol (2012) 0.79
Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. J Thromb Haemost (2013) 0.79
Low frequency of symptomatic venous thromboembolism after multiligamentous knee reconstruction with thromboprophylaxis. Clin Orthop Relat Res (2014) 0.76
Low-molecular-weight heparin for 7 days was more effective than compression stockings for preventing DVT in knee arthroscopy. ACP J Club (2008) 0.75
Thromboprophylaxis in knee arthroscopy patients: revisiting values and preferences. Ann Intern Med (2008) 0.75
PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ORTHOPAEDIC SURGERY. Rev Bras Ortop (2015) 0.75
Thigh length versus knee length antiembolism stockings for the prevention of deep vein thrombosis in postoperative surgical patients; a systematic review and network meta-analysis. BMJ Open (2016) 0.75
Is low-molecular-weight heparin suitable in all patients undergoing knee arthroplasty? Ann Intern Med (2008) 0.75
[Prevention of venous thromboembolism in musculoskeletal surgery]. Wien Klin Wochenschr (2014) 0.75
[Perioperative thromboprophylaxis in adults]. Wien Med Wochenschr (2009) 0.75
Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med (2012) 10.64
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med (2004) 5.68
Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med (2010) 5.65
Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ (2007) 3.88
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med (2004) 3.74
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet (2007) 3.66
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood (2002) 3.59
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med (2002) 3.51
An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39
Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics (2008) 3.27
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol (2006) 2.61
Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke (2006) 2.54
SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology (2009) 2.45
Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics (2008) 2.42
The effect of low molecular weight heparin on survival in patients with advanced malignancy. J Clin Oncol (2005) 2.31
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med (2003) 2.28
Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation (2010) 2.12
Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet (2011) 2.09
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica (2007) 2.00
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost (2008) 1.91
Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood (2008) 1.90
Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int (2012) 1.87
A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J (2004) 1.80
Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood (2009) 1.80
The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation (2014) 1.64
The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med (2007) 1.63
Different guidelines for imaging after first UTI in febrile infants: yield, cost, and radiation. Pediatrics (2013) 1.59
Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study. Thromb Haemost (2006) 1.57
Procalcitonin as a predictor of renal scarring in infants and young children. Pediatr Nephrol (2009) 1.49
Upper extremity deep vein thrombosis. Intern Emerg Med (2009) 1.49
The efficacy and the risk of immunogenicity of FIX Padua (R338L) in hemophilia B dogs treated by AAV muscle gene therapy. Blood (2012) 1.48
Benign outcome of objectively proven spontaneous recanalization of internal carotid artery occlusion. J Vasc Surg (2010) 1.45
A prospective study on survival in cancer patients with and without venous thromboembolism. Intern Emerg Med (2013) 1.42
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. Blood (2013) 1.39
Aneurysm sac "thrombization" and stabilization in EVAR: a technique to reduce the risk of type II endoleak. J Endovasc Ther (2010) 1.39
Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood (2013) 1.39
Mechanism of gender-specific differences in aortic stiffness with aging in nonhuman primates. Circulation (2007) 1.38
Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology (2006) 1.27
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation (2008) 1.26
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. Blood (2002) 1.23
Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int (2012) 1.21
Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1. Pediatrics (2009) 1.21
Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med (2004) 1.15
Upper extremity deep venous thrombosis. Semin Thromb Hemost (2006) 1.14
Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost (2010) 1.11
Superficial vein thrombosis: risk factors, diagnosis, and treatment. Semin Thromb Hemost (2006) 1.11
Sex and anticoagulation in patients with idiopathic venous thromboembolism. Lancet (2006) 1.11
Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med (2002) 1.09
Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med (2002) 1.05
Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost (2005) 1.04
Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis. J Urol (2007) 1.04
Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol (2009) 1.04
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood (2002) 1.02
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study. J Hepatol (2010) 1.01
Duplex system ureterocele in infants: should we reconsider the indications for secondary surgery after endoscopic puncture or partial nephrectomy? J Pediatr Urol (2012) 1.01
Confirmatory tests in the diagnosis of brain death: comparison between SPECT and contrast angiography. Crit Care Med (2005) 1.01
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica (2007) 0.98
Superficial and deep venous thrombosis, pulmonary embolism and subsequent risk of cancer. Eur J Cancer (2011) 0.97
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. BMJ (2004) 0.96
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study. Nucl Med Commun (2006) 0.94
The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost (2002) 0.93
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost (2006) 0.93
Endothelial dysfunction in patients with spontaneous venous thromboembolism. Haematologica (2007) 0.93
Increased apoptosis and myocyte enlargement with decreased cardiac mass; distinctive features of the aging male, but not female, monkey heart. J Mol Cell Cardiol (2007) 0.92
Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab (2003) 0.92
Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation. FEBS J (2005) 0.91
Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis. Circulation (2011) 0.89
ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus (2012) 0.89
Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts. Transplantation (2005) 0.89
Cancer Screening in Unprovoked Venous Thromboembolism. N Engl J Med (2015) 0.89
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb Res (2011) 0.89
Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. Thromb Haemost (2013) 0.88
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis. Thromb Haemost (2010) 0.87
Selective decrease in urinary aquaporin 2 and increase in prostaglandin E2 excretion is associated with postobstructive polyuria in human congenital hydronephrosis. J Am Soc Nephrol (2004) 0.87
18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol (2008) 0.87
Warfarin versus low-molecular-weight heparin therapy in cancer patients. Oncologist (2005) 0.86
Left ventricular dyssynchrony resulting from right ventricular apical pacing: relevance of baseline assessment. Pacing Clin Electrophysiol (2008) 0.86
Cardiopulmonary anatomy and function in long-term survivors of mild to moderate congenital diaphragmatic hernia. J Pediatr Surg (2004) 0.86
Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism. Rationale for and design of the EINSTEIN CHOICE study. Thromb Haemost (2015) 0.85
Thrombophilia as a predictor of persistent residual vein thrombosis. Haematologica (2008) 0.85
Gender differences on the effects of aging on cardiac and peripheral adrenergic stimulation in old conscious monkeys. Am J Physiol Heart Circ Physiol (2003) 0.85